MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases

Clinical trial NCT05417282 · COMPLETED

Trial details

NCT number: NCT05417282
Sponsor: ImmunoChem Therapeutics, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cognitive Dysfunction, Cognitive Disorder

Start date: 2022-07-01
Primary completion: 2025-07-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.